Screener
Astrana Health ASTH Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:StockIssued1.
The source filing: Astrana Health’s 10-K, filed March 12, 2026.
- Filed
- Mar 12, 2026, 8:11 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-103128
| Line item | Years ended December 31, 2025 | Years ended December 31, 2024 | Years ended December 31, 2023 |
|---|---|---|---|
| Cash paid for interest | $45,767 | $30,419 | $14,251 |
| Supplemental disclosures of non-cash investing and financing activities | |||
| Right-of-use assets obtained in exchange for operating lease liabilities | $11,875 | $14,117 | $25,124 |
| Common stock issued in business combination | — | $21,952 | $800 |
| Common stock issued for contingent consideration payment | $2,600 | $4,023 | — |
| Acquisition of business through loan conversion | — | $5,175 | — |
| Draw on letter of credit through Revolver Loan | — | $4,732 | — |
| Tax impact from APC dividends to APC Shareholders | — | — | $3,076 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Astrana Health's stock issuance proceeds?
- Astrana Health (ASTH) reported stock issuance proceeds of $0 in Q4 2025.
- How has Astrana Health's stock issuance proceeds changed year-over-year?
- Astrana Health's stock issuance proceeds decreased by 100.0% year-over-year, from $21.72M to $0.
- What is the long-term trend for Astrana Health's stock issuance proceeds?
- Over 3 years (2021 to 2025), Astrana Health's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $40.14M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Astrana Health's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude